Sign in →

Test ID BLOD1527 Alpha-2 Plasmin Inhibitor, Plasma

Useful For

Diagnosing congenital alpha-2 plasmin inhibitor deficiencies (rare)

 

Providing a complete assessment of disseminated intravascular coagulation, intravascular coagulation and fibrinolysis, or hyperfibrinolysis (primary fibrinolysis), when measured in conjunction with fibrinogen, fibrin D-dimer, fibrin degradation products, soluble fibrin monomer complex, and plasminogen

 

Evaluating liver disease

 

Evaluating the effects of fibrinolytic or antifibrinolytic therapy

Specimen Type

Plasma Na Cit


Specimen Required


Specimen Type: Platelet-poor plasma

Collection Container/Tube: Light-blue top (3.2% sodium citrate)

Submission Container/Tube: Plastic vial

Specimen Volume: 1 mL

Collection Instructions:

1. For complete instructions, see Coagulation Guidelines for Specimen Handling and Processing.

2. Centrifuge, transfer all plasma into a plastic vial, and centrifuge plasma again.

3. Aliquot plasma into a plastic vial leaving 0.25 mL in the bottom of centrifuged vial.

4. Freeze plasma immediately (no longer than 4 hours after collection) at -20° C or, ideally, -40° C or below.

Additional Information:

1. Double-centrifuged specimen is critical for accurate results as platelet contamination may cause spurious results.

2. Each coagulation assay requested should have its own vial.


Specimen Minimum Volume

0.5 mL

Reject Due To

Gross hemolysis Reject
Gross lipemia Reject
Gross icterus Reject

Specimen Stability Information

Specimen Type Temperature Time Special Container
Plasma Na Cit Frozen 14 days

Day(s) Performed

Monday through Friday

Report Available

3 to 7 days

Method Name

Chromogenic

Performing Laboratory

Mayo Clinic Laboratories in Rochester

CPT Code Information

85410

Secondary ID

602169

Reporting Name

Alpha-2 Plasmin Inhibitor, P

Reference Values

Adults: 80-140%

Normal, full-term, and premature infants may have mildly decreased levels (≥50%) that reach adult levels within 90 days postnatal.*

*See Pediatric Hemostasis References section in Coagulation Guidelines for Specimen Handling and Processing.

Test Classification

This test has been modified from the manufacturer's instructions. Its performance characteristics were determined by Mayo Clinic in a manner consistent with CLIA requirements. This test has not been cleared or approved by the US Food and Drug Administration.

Forms

If not ordering electronically, complete, print, and send a Coagulation Test Request (T753) with the specimen.

Sanford Laboratories - Fargo Additional Information:

SANFORD LABORATORY INTERFACE BUILD INFORMATION

 Result Code     Result Code Description   
 21212  Alpha-2 Plasmin Inhibitor, P